Cargando…
Ultrasound-enhanced delivery of Morpholino with Bubble liposomes ameliorates the myotonia of myotonic dystrophy model mice
Phosphorodiamidate morpholino oligonucleotide (PMO)-mediated control of the alternative splicing of the chloride channel 1 (CLCN1) gene is a promising treatment for myotonic dystrophy type 1 (DM1) because the abnormal splicing of this gene causes myotonia in patients with DM1. In this study, we opti...
Autores principales: | Koebis, Michinori, Kiyatake, Tamami, Yamaura, Hiroshi, Nagano, Kanako, Higashihara, Mana, Sonoo, Masahiro, Hayashi, Yukiko, Negishi, Yoichi, Endo-Takahashi, Yoko, Yanagihara, Dai, Matsuda, Ryoichi, Takahashi, Masanori P., Nishino, Ichizo, Ishiura, Shoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718203/ https://www.ncbi.nlm.nih.gov/pubmed/23873129 http://dx.doi.org/10.1038/srep02242 |
Ejemplares similares
-
Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice
por: Oana, Kosuke, et al.
Publicado: (2013) -
Type 1 Myotonic Dystrophy Presenting with Bulbar Weakness without Myotonia
por: Juneja, Abhishek, et al.
Publicado: (2021) -
The Myotonic Plot Thickens: Electrical Myotonia in Antimuscle-Specific Kinase Myasthenia Gravis
por: Magnussen, Marcus, et al.
Publicado: (2015) -
Relationships between grip strength, myotonia, and CTG expansion in myotonic dystrophy type 1
por: Hogrel, Jean‐Yves, et al.
Publicado: (2017) -
Paxilline Prevents the Onset of Myotonic Stiffness in Pharmacologically Induced Myotonia: A Preclinical Investigation
por: Hoppe, Kerstin, et al.
Publicado: (2020)